[{"address1": "535 W 24th Street", "address2": "5th Floor", "city": "New York", "state": "NY", "zip": "10011", "country": "United States", "phone": "855 508 3568", "website": "https://www.neurogene.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Neurogene Inc., a clinical stage biotechnology company, develops genetic medicines for rare neurological diseases. The company's product candidates include NGN-401 that is packaged in an adeno-associated virus 9, which is in Phase 1/2 clinical trial for the treatment of Rett syndrome; and NGN-101, a conventional gene therapy candidate that is in Phase 1/2 clinical trial to treat CLN5 Batten disease. It has a license agreements with The University of Edinburgh, Virovek, Inc., Sigma-Aldrich Co. LLC., and Leland Stanford Junior University. The company was founded in 2018 and is headquartered in New York, New York.", "fullTimeEmployees": 107, "companyOfficers": [{"maxAge": 1, "name": "Dr. Rachel L. McMinn Ph.D.", "age": 51, "title": "Founder, Executive Chair & CEO", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 929410, "exercisedValue": 0, "unexercisedValue": 249075}, {"maxAge": 1, "name": "Ms. Christine Mikail Cvijic J.D.", "age": 46, "title": "President & CFO", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 746750, "exercisedValue": 0, "unexercisedValue": 1035052}, {"maxAge": 1, "name": "Dr. Julie  Jordan M.D.", "age": 52, "title": "Chief Medical Officer", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 651036, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Arvind  Sreedharan", "title": "Senior Vice President of Business Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stuart  Cobb Ph.D.", "age": 53, "title": "Chief Scientific Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 478807, "exercisedValue": 0, "unexercisedValue": 338906}, {"maxAge": 1, "name": "Ms. Donna M. Cochener-Metcalfe J.D.", "age": 49, "title": "Senior VP, General Counsel & Corporate Secretary", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Effie  Albanis M.D.", "title": "Senior Vice President of Early Clinical & Translational Research", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrew E. Mulberg CPI, FAAP, M.D.", "title": "Senior Vice President of Regulatory Affairs, Quality Assurance & Quality Control", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ricardo  Jimenez", "title": "Senior Vice President of Technical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 7, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 15.4, "open": 15.54, "dayLow": 15.54, "dayHigh": 17.45, "regularMarketPreviousClose": 15.4, "regularMarketOpen": 15.54, "regularMarketDayLow": 15.54, "regularMarketDayHigh": 17.44, "payoutRatio": 0.0, "forwardPE": -3.6573277, "volume": 199877, "regularMarketVolume": 199877, "averageVolume": 279445, "averageVolume10days": 232150, "averageDailyVolume10Day": 232150, "bid": 16.81, "ask": 17.17, "bidSize": 2, "askSize": 1, "marketCap": 242027824, "fiftyTwoWeekLow": 6.875, "fiftyTwoWeekHigh": 74.49, "priceToSalesTrailing12Months": 261.6517, "fiftyDayAverage": 14.1982, "twoHundredDayAverage": 28.7059, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -46622264, "profitMargins": 0.0, "floatShares": 5106210, "sharesOutstanding": 14262100, "sharesShort": 2860015, "sharesShortPriorMonth": 2179819, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.2005, "heldPercentInsiders": 0.10632, "heldPercentInstitutions": 1.13345, "shortRatio": 7.67, "shortPercentOfFloat": 0.222, "impliedSharesOutstanding": 15871100, "bookValue": 20.894, "priceToBook": 0.8121949, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -75144000, "trailingEps": -4.28, "forwardEps": -4.64, "lastSplitFactor": "1:4", "lastSplitDate": 1702944000, "enterpriseToRevenue": -50.402, "enterpriseToEbitda": 0.587, "52WeekChange": -0.48277962, "SandP52WeekChange": 0.09765589, "quoteType": "EQUITY", "currentPrice": 16.97, "targetHighPrice": 72.0, "targetLowPrice": 16.0, "targetMeanPrice": 44.4, "targetMedianPrice": 46.0, "recommendationMean": 1.28571, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 312404992, "totalCashPerShare": 20.925, "ebitda": -79358000, "totalDebt": 12428000, "quickRatio": 20.654, "currentRatio": 20.843, "totalRevenue": 925000, "debtToEquity": 4.004, "revenuePerShare": 0.053, "returnOnAssets": -0.18495001, "returnOnEquity": -0.30276, "grossProfits": -3583000, "freeCashflow": -49417624, "operatingCashflow": -70603000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -89.3027, "financialCurrency": "USD", "symbol": "NGNE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1746227080, "regularMarketTime": 1746216000, "exchange": "NGM", "messageBoardId": "finmb_602062523", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 10.194804, "regularMarketPrice": 16.97, "shortName": "Neurogene Inc.", "longName": "Neurogene Inc.", "marketState": "CLOSED", "earningsTimestampEnd": 1747053000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -4.28, "epsForward": -4.64, "epsCurrentYear": -3.815, "priceEpsCurrentYear": -4.4482303, "fiftyDayAverageChange": 2.771799, "fiftyDayAverageChangePercent": 0.19522186, "twoHundredDayAverageChange": -11.735901, "twoHundredDayAverageChangePercent": -0.40883237, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1394202600000, "postMarketChangePercent": 3.12316, "postMarketPrice": 17.5, "postMarketChange": 0.530001, "regularMarketChange": 1.5699997, "regularMarketDayRange": "15.54 - 17.44", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 279445, "fiftyTwoWeekLowChange": 10.094999, "fiftyTwoWeekLowChangePercent": 1.4683635, "fiftyTwoWeekRange": "6.875 - 74.49", "fiftyTwoWeekHighChange": -57.519997, "fiftyTwoWeekHighChangePercent": -0.77218413, "fiftyTwoWeekChangePercent": -48.27796, "earningsTimestamp": 1742847000, "earningsTimestampStart": 1746707400, "displayName": "Neurogene", "trailingPegRatio": null, "__fetch_time": "2025-05-03"}]